NEWS October 2022 to July 2025 We started the following clinical trial “A phase 1 first in human study evaluating safety, pharmacokinetics and efficacy of ABBV-400 in adult subjects with adult subjects with advanced solid tumors” 2022年10月1日
NEWS September 2022 to May 2025 We started the following clinical trial “A study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors” 2022年9月1日
NEWS August to December 2022 We started the following clinical trial “An Open-Label, Dose Escalation, Phase 1, First-in Human Study of TAK-102 in Adult Patients with GPC3-Expressing Previously Treated Solid Tumors” 2022年8月1日
NEWS “Study on age-related changes in human immunocompetent cells” (new research on new coronavirus vaccine) has started. 2022年4月19日
NEWS April 2022 to March 2024 We started the following clinical trial “Investigation of Colorectal Cancer-Related Genes Using Peripheral Blood in Healthy Volunteers” 2022年4月1日
NEWS April 2020 to March 2023. Takako Nakajima (Principal Investigator) implementing the project(Health Labour Sciences Research Grant). “Research to establish guideline and social implementation of electronic patient-reported outcome” 2022年4月1日
NEWS April 2022 to March 2024 Takeshi Sawada (Principal Investigator) is implementing the project (Grants-in-Aid for Young Scientists（MEXT）“Study on mitochondrial DNA in cancer cells using mitochondrial DNA repraced cells” 2022年4月1日
NEWS April 2022 to March 2025 Masahiko Aoki (Principal Investigator) is implementing the project (Grants-in-Aid for young Scientists(MEXT))“Establishment of new drug sensitivity test using patient-derived cancer organoids from CTOS method” 2022年4月1日
NEWS Next Generation Medical and iPS Cell Therapy Research Center (Ki-CONNECT) Early Medical Development Department A new specific lecturer, Sawada, has been appointed. 2022年4月1日
